在癌症治疗中的帕拉普的意义及其由自然分子诱导的诱导
Shivam Rajput1, Rishabha Malviya1, Sathvik Belagodu Sridhar2
1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.
Current topics in medicinal chemistry
|February 24, 2026
概括
帕拉,一种独特的编程细胞死亡 (PCD) 形式,通过诱导细胞通过真空球形成死亡,为抗治疗耐药癌症提供了一种新的策略. 了解亡机制是开发新的小分子癌症疗法的关键.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 编程细胞死亡 (PCD) 对平衡,发育和疾病调节至关重要.
- 癌细胞经常避开常见的PCD - - 亡,因此需要使用替代细胞死亡策略.
- 帕拉普症是一种独特的PCD机制,涉及线粒体和ER缩,呈现出一个有前途的治疗途径.
研究的目的:
- 探索帕帕托斯作为一种新的癌症治疗策略.
- 阐明帕帕托斯的机制,诱导剂和调节剂.
- 为了区分帕帕托斯与其他PCD途径,如亡和自.
主要方法:
- 综述现有的文献在帕帕托斯.
- 对帕帕托斯特征的分析:蛋白质静止,离子不平衡,从ER形成真空球.
- 基于形态学和生物化学的帕帕托斯与亡和自的比较.
主要成果:
- 帕拉普症的特征是来自ER的细胞质真空球形成,与其他PCD类型不同.
- 它不需要酶激活,并表现出独特的形态和生化特征.
- 天然化合物,金属复合物和新型诱导剂已证明在引发癌细胞亡方面具有有效性.
结论:
- 亡是一种可行的替代细胞死亡途径,可以克服抗癌治疗的阻力.
- 进一步了解亡调节剂对于开发向的小分子癌症药物至关重要.
- 向性亡对创新的癌症治疗开发有很大的潜力.
相关概念视频
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
Overview of Cell Death
10.5K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.5K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
The Extrinsic Apoptotic Pathway
9.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K
Apoptosis
16.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.0K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K


